Muscle Invasive Bladder Cancer: Examining Survivor Burden and Unmet Needs

被引:92
|
作者
Mohamed, Nihal E. [1 ]
Herrera, Phapichaya Chaoprang [1 ]
Hudson, Shawna [4 ]
Revenson, Tracey A. [2 ]
Lee, Cheryl T. [5 ]
Quale, Diane Z. [6 ]
Zarcadoolas, Christina [3 ]
Hall, Simon J. [1 ]
Diefenbach, Michael A. [1 ]
机构
[1] Mt Sinai, Icahn Sch Med, Dept Urol & Oncol Sci, New York, NY 10029 USA
[2] CUNY, Grad Ctr, Doctoral Program Psychol, New York, NY USA
[3] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA
[4] Rutgers Robert Wood Johnson Med Sch, Dept Family Med & Community Hlth, New Brunswick, NJ USA
[5] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[6] Bladder Canc Advocacy Network, Bethesda, MD USA
来源
JOURNAL OF UROLOGY | 2014年 / 191卷 / 01期
关键词
urinary bladder neoplasms; neoplasm invasiveness; survivors; health services needs and demands; quality of life; CARE NEEDS; FOLLOW-UP; CYSTECTOMY;
D O I
10.1016/j.juro.2013.07.062
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Although improvements in perioperative care have decreased surgical morbidity after radical cystectomy for muscle invasive bladder cancer, treatment side effects still have a negative impact on patient quality of life. We examined unmet patient needs along the illness trajectory. Materials and Methods: A total of 30 patients (26.7% women) treated with cystectomy and urinary diversion for muscle invasive bladder cancer participated in the study. Patients were recruited from the Department of Urology at Mount Sinai and through advertisements on the Bladder Cancer Advocacy Network (BCAN) website between December 2011 and September 2012. Data were collected at individual interviews, which were audiotaped and transcribed. Transcribed data were quantitatively analyzed to explore key unmet needs. Results: At diagnosis unmet informational needs were predominant, consisting of insufficient discussion of certain topics, including urinary diversion options and their side effects, self-care, the recovery process and medical insurance. Unmet psychological needs related to depression, and worries about changes in body image and sexual function were reported. Postoperative unmet needs revolved around medical needs (eg pain and bowel dysfunction) and instrumental needs (eg need of support for stomal appliances, catheters and incontinence). During survivorship (ie 6 to 72 months postoperatively) unmet needs centered around psychological support (ie depression, poor body image and sexual dysfunction) and instrumental support (eg difficulty adjusting to changes in daily living). Conclusions: Meeting patient needs is imperative to ensure adequate patient involvement in health care and enhance postoperative quality of life. An effective support provision plan should follow changes in patient needs.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 50 条
  • [41] Bladder Preserving Treatment in Patients with Muscle Invasive Bladder Cancer
    Yu, Jeong Il
    Park, Won
    Oh, Dong Ryol
    Huh, Seung Jae
    Choi, Han Yong
    Lee, Hyon Moo
    Jeon, Seong Soo
    Yim, Ho Young
    Kim, Won Suk
    Lim, Do Hoon
    Ahn, Yong Chan
    RADIATION ONCOLOGY JOURNAL, 2007, 25 (02): : 70 - 78
  • [42] Bladder sparing options for muscle-invasive bladder cancer
    Laukhtina, Ekaterina
    Moschini, Marco
    Teoh, Jeremy Yuen-Chun
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2024, 34 (06) : 471 - 476
  • [43] Current management in muscle invasive bladder cancer
    Witjes, J. A.
    BJU INTERNATIONAL, 2008, 101 : 26 - 26
  • [44] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17
  • [45] Update on the management of muscle invasive bladder cancer
    Van Poppel, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S79 - S79
  • [46] Perioperative chemotherapy for muscle invasive bladder cancer
    Rudzinski, Jan K.
    Basappa, Naveen S.
    North, Scott
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2015, 9 (03) : 249 - 254
  • [47] Perioperative Therapy for Muscle Invasive Bladder Cancer
    Leow, Jeffrey J.
    Fay, Andre P.
    Mullane, Stephanie A.
    Bellmunt, Joaquim
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 301 - +
  • [48] Clinical understaging of muscle invasive bladder cancer
    Mezentsev, V.
    Pronisceva, V.
    Kimuli, M.
    Cooksey, G.
    BJU INTERNATIONAL, 2007, 99 : 18 - 18
  • [49] Chemotherapy for Muscle-Invasive Bladder Cancer
    Trenta, Patrizia
    Calabro, Fabio
    Cerbone, Linda
    Sternberg, Cora N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
  • [50] Prognostic factors for muscle invasive bladder cancer
    Hofmann, R
    Krüsmann, J
    Lehmer, A
    Hartung, R
    JOURNAL OF UROLOGY, 1998, 159 (05): : 246 - 246